Company Profiles

driven by the PitchBook Platform

Anokion

Description

Provider of antigen-specific immunotherapy. The company offers antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases.

2012

Founded

PRIVATE

Status

11-50

Employees

Corporate

Latest Deal Type

$45M

Latest Deal Amount

$82.5M

Total Amount Raised

Description

Provider of antigen-specific immunotherapy. The company offers antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases.

Website:

www.anokion.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Biotechnology

Primary Office

EPFL Innovation Park-L Chemin de la Dent d'Ochoe 1A 1024 EcublensSwitzerland +41 (0)21 693 7237
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Anokion's full profile, request a free trial.

    Anokion Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Anokion Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    CelgeneCorporationMinority000 0000000 0000
    EPFL Innovation ParkAccelerator/IncubatorMinority000 0000000 0000
    Novartis Venture FundCorporate Venture CapitalMinority000 0000000 0000
    NovoCorporate Venture CapitalMinority000 0000000 0000
    Versant Venture ManagementVenture CapitalMinority000 0000000 0000
    Celgene Corporation
    EPFL Innovation Park Accelerator/Incubator
    Novartis Venture Fund Corporate Venture Capital
    Novo Corporate Venture Capital
    Versant Venture Management Venture Capital

    Anokion Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Jens Kurth Ph.DChief Technology Officer
    Kristen Lorentz Ph.DCo-Founder & Senior Director - Immunology
    Stephan Kontos Ph.DCo-Founder & Vice President, Research
    David Lowin JDCo-Founder
    Melody Swartz Ph.DCo-Founder
    Jens Kurth Ph.D Chief Technology Officer
    Kristen Lorentz Ph.D Co-Founder & Senior Director - Immunology
    Stephan Kontos Ph.D Co-Founder & Vice President, Research
    David Lowin JD Co-Founder
    Melody Swartz Ph.D Co-Founder

    Anokion Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    André MuellerSelfBoard Member000 0000
    Florent GrosNovartis Venture FundCo-Managing Director000 0000
    Harry WeltenSelfBoard Member000 0000
    Jack Bech NielsenNovoSenior Partner, Ventures000 0000
    Michael Clayman MDSelfBoard Member000 0000
    André Mueller Board Member Self
    Florent Gros Co-Managing Director Novartis Venture Fund
    Harry Welten Board Member Self
    Jack Bech Nielsen Senior Partner, Ventures Novo
    Michael Clayman MD Board Member Self
    Request full access to PitchBook